Proposition 1 definition

Proposition 1 means City of SeaTac Proposition 1, codified at Ch. 7.45 SMC.
Sample 1Sample 2Sample 3
Proposition 1. In a convergent socioeconomic hierarchy, the dominant group proposes a power-sharing language regime regardless of the second-period uncertainty. ,n So what happens when the socioeconomic hierarchy is non-convergent, such that the politically non-dominant group is the socioeconomically advantaged group? Figure 3.3 presents four 3D plots using the same parameter specifications as those in Figure 3.2. The setup for each 3D plot remains the same: The width axis is the likelihood the dominant group remains in power (α ) ; the depth axis, the likelihood the non-dominant group comes to power ( β ) ; and the height axis, the optimal proportion for each of the three languages (n ,n * * A1 B1 * LF 1
Sample 1
Proposition 1. For SD with pe < cr , there exists a critical value ca of the abatement cost such that:
Sample 1

Examples of Proposition 1 in a sentence

  • With regard to Proposition 1 bond act funding, see Chapter 4, 79711(e) “Nothing in this division [bond act] shall be construed to affect the California Wild and Scenic Rivers Act (Chapter 1.4 (commencing line 5 with Section 5093.50) of Division 5 of the Public Resources Code) or the federal Wild and Scenic Rivers Act (16 U.S.C. Sec.

  • A plan for acknowledgement of Conservancy funding and Proposition 1 as the source of that funding.

  • Proposition 1 tells us that the value of a collateralized contract is equal to the present value of the payoff discounted by the CSA-adjusted discount factor minus the cost of taking unsecured counterparty credit risk.

  • This reflects the result of Proposition 1 and implies that it is only the environment that determinates agent i's decision to trust.If r is smaller than w, one can interpret the results analogously to the case r>w.

  • The State shall provide funding from the Water Quality, Supply, and Infrastructure Improvement Act of 2014 (Proposition 1) to the Grantee to assist in financing the projects, which are included in and implemented in an adopted Integrated Regional Water Management Plan (IRWM Plan), pursuant to Chapter 7.

  • The purposes of Proposition 1 include generating funding to address water quality, water supply and watershed protection and restoration.

  • This proposition theoretically demonstrates that collateral posting changes valuation.The pricing in Proposition 1 is relatively straightforward.

  • Proposition 1 shows how the optimal settlement offer depends on the distribution of damages as well as the litigation and delay costs.

  • These results seem to be in line with other risk aversion elicitation exercises in the literature.7 Recall from Table 2 and Proposition 1 that the lotteries were designed to predict asset choices under the assumption that subjects have CRRA utility functions.

  • Water sustainability projects are consistent with the purposes of Chapter 6 of Proposition 1.


More Definitions of Proposition 1

Proposition 1 means AB 1471, (2014), as codified in California Water Codes section 79701 et seq.
Sample 1
Proposition 1 or “Prop 1” means Assembly Bill 1471, Rendon.
Sample 1
Proposition 1. With quantity competition and uncertain firm specific cost or demand intercept, a firm unilaterally chooses to share information if and only if B ≤ δ2(8−δ2)/12. A firm’s profit is greater when both share information than when neither share if and only if B ≤ δ2(12−δ2)/3(4+δ2). Proof: From (1) and (2), firm a’s expected profit when they both do not share less its expected profit when only firm a shares, is increasing in B, and equals zero at B = δ2(8−δ2)/12. From (3) and (4), the same is true for firm a’s expected profit when only it does not share less its expected profit when they both share. For the second part, from (2) and (3), firm a’s expected profit when they both do not share less its expected profit when they both share, is increasing in B and equals at B = δ2(12−δ2)/3(4+δ2).// 14 There are two effects that arise from a firm sharing its information. On one hand, the union can exploit the information to the firm’s detriment. On the other hand, the information being shared with the rival creates a benefit. In the environment here, the gain from sharing is greater than the loss from the union learning, if the union is sufficiently weak or the products are sufficiently undifferentiated. It is interesting to contrast these results to those found in Li (2002) who assumes that the union has all of the pricing power and the products are perfect substitutes (equivalent to B = 1 and δ=1). In contrast to the result here, Xx (2002) finds that the firm’s dominant strategy is to share information and profits are greater if all firms share information. The difference arises because here the union sets different wages, while in Li (2002) a uniform price is considered.15 By setting a differential wage the extent to which the union can exploit the information is enhanced sufficiently to change the results found in Li. Comparison of the pricing power (B) needed for joint profits to increase from information sharing (δ2(12−δ2)/3(4+δ2)) to that needed for an individual firm to unilaterally share information (δ2(8−δ2)/12), reveals that there are levels of pricing power such that there is a prisoner’s dilemma. Interestingly, this only arises if the pricing power is more evenly divided.
Sample 1

Related to Proposition 1

  • Ballot proposition means a question, issue, or proposal that is submitted to voters

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • Phase I means the first part of the tuition incentive assistance program defined as the academic period of 80 semester or 120 term credits, or less, leading to an associate degree or certificate.

  • Phase 2 means the second implementation phase of this section, beginning June 1, 2022 and continuing thereafter.

  • Phase III means Phase I (or Phase I/II), Phase II (or Phase II/III) and Phase III clinical trials, respectively, in each case as prescribed by applicable FDA IND Regulations, or any corresponding foreign statutes, rules or regulations.

  • Waste Framework Directive or “WFD” means Waste Framework Directive 2008/98/EC of the European Parliament and of the Council on waste

  • Completion Deadline means the date by which the Arrangement is to be completed, which date shall be April 30, 2014 or such later date as may be agreed to in writing by the Parties;

  • conformity assessment means the process demonstrating whether the requirements of this Regulation relating to a device have been fulfilled;

  • Project Proponent means the individual or organization that has overall control and responsibility for the Project, or an individual or organization that together with others, each of which is also a Project Proponent, has overall control or responsibility for the Project. The entity(s) that can demonstrate Project Ownership in respect of the Project. For the avoidance of doubt where an individual executes this Representation in their capacity as an authorized office holder of the company who is the Project Proponent, this Representation is made by the company, not the authorized office holder;

  • Remediation waste management site means a facility where an owner or operator is or will be treating, storing or disposing of hazardous remediation wastes. A remediation waste management site is not a facility that is subject to corrective action under § 264.101 of this regulation, but is subject to corrective action requirements if the site is located in such a facility.

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Phase II means the second part of the tuition incentive assistance program which provides assistance in the third and fourth year of 4-year degree programs.

  • Project Proposal is the final and written description of the Project as described in Exhibit A, to be undertaken by Sub-recipient for which the Project Funds is granted and performance is required and monitored pursuant to this PFA.

  • Remediation waste means all solid and hazardous wastes, and all media (including groundwater, surface water, soils, and sediments) and debris that are managed for implementing cleanup.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Proposal means the Technical Proposal and the Financial Proposal.

  • Improvement Plan means the plan required by the Authority from the Supplier which shall detail how the Supplier will improve the provision of the Goods and/or Services pursuant to Clause 29.1.1 (Authority Remedies);

  • project completion period means the period of sixty (60) months commencing from and expiring on for the construction and obtaining of Temporary Occupation Permit or Permits for the whole of the Development as provided in clause 3.3;

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Affordable development means a housing development all or a portion of which consists of restricted units.

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase I assessment as described in, and meeting the criteria of, (i) Chapter 5 of the FNMA Multifamily Guide or any successor provisions covering the same subject matter in the case of a Specially Serviced Mortgage Loan as to which the related Mortgaged Property is multifamily property or (ii) the American Society for Testing and Materials in the case of Specially Serviced Mortgage Loan as to which the related Mortgaged Property is not multifamily property.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).